Zhejiang Jingxin Pharmaceutical Co. Ltd.
http://www.jingxinpharm.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Zhejiang Jingxin Pharmaceutical Co. Ltd.
Pharmula Acquisition To Provide US Expansion Base For Jingxin
Shanghai-listed Jingxin Pharmaceutical is aiming to tap into the US market for its growing formulations business through the majority acquisition of Pharmula, a US-based contract services firm. The Chinese manufacturer is looking to capitalize on its partners’ strength in R&D to facilitate its global expansion.
15 Chinese Formulation Makers Receive Export Licenses From 29 Nations
Fifteen Chinese formulation producers have recently acquired pharma quality certificates from 29 overseas countries including the U.S., Japan, and 27 European countries.
Deals Shaping the Medical Industry (12/2010)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions
Company Information
- Industry
- Contract Research Organization-CRO
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- Vaccines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice